Compare XLO & ATCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XLO | ATCX |
|---|---|---|
| Founded | 2016 | 2016 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.8M | 39.0M |
| IPO Year | 2021 | N/A |
| Metric | XLO | ATCX |
|---|---|---|
| Price | $0.57 | $6.63 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 572.5K | 176.0K |
| Earning Date | 03-10-2026 | 03-16-2023 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $31,804,000.00 | $367,030.00 |
| Revenue This Year | $626.78 | $109,631.07 |
| Revenue Next Year | $79.08 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 588.40 | N/A |
| 52 Week Low | $0.50 | $4.80 |
| 52 Week High | $1.70 | $47.16 |
| Indicator | XLO | ATCX |
|---|---|---|
| Relative Strength Index (RSI) | 45.49 | 42.76 |
| Support Level | $0.50 | $6.11 |
| Resistance Level | $0.61 | $7.39 |
| Average True Range (ATR) | 0.04 | 1.26 |
| MACD | 0.00 | -0.21 |
| Stochastic Oscillator | 55.80 | 4.10 |
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.
Atlas Critical Minerals Corporation, is a mineral exploration and development company focused on critical minerals projects and properties in Brazil. The company's portfolio principally includes mineral properties for rare earths, graphite, titanium, copper, uranium, and nickel. It also owns mineral rights for iron ore, quartzite, gold, and diamond properties. The company's project portfolio includes the Alto Paranaiba, Malacacheta, Arcos, Goias, Tocantins, Rio Piracicaba, and other projects.